Go back

Innovation ‘most important part’ of forthcoming EU pharma strategy

Image: European Union


Health commissioner promises “strong incentives” for innovation amid industry concern

Supporting industry innovation will be the most important part of the EU’s upcoming proposal for a pharmaceutical strategy, according to the politician leading its development.

Industry expects the European Commission to publish its proposal for revising the bloc’s pharmaceutical regulation by the end of the month. Based on leaked drafts, representatives have expressed concern about the plans, with the European Federation of Pharmaceutical Industries and Associations warning they could “irretrievably sabotage [the] industry”.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.